|
2025-06-18 |
2025-06-17 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
911
-1.8%
30,24
27.549 USD
|
911
-1.8%
|
30,24
|
27.549 USD
|
|
|
2025-06-12 |
2025-06-11 |
GV
Geplanter Verkauf
|
Flanagan W. Michael
Chief Scientific Officer
Führungsperson
|
20.000
-20.0%
32,88
657.694 USD
|
20.000
-20.0%
|
32,88
|
657.694 USD
|
|
|
2025-06-04 |
2025-06-02 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
5.875
-10.4%
32,48
190.833 USD
|
5.875
-10.4%
|
32,48
|
190.833 USD
|
|
|
2025-05-02 |
2025-05-01 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
5.875
-10.4%
32,40
190.324 USD
|
5.875
-10.4%
|
32,40
|
190.324 USD
|
|
|
2025-04-03 |
2025-04-01 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
329
-0.6%
27,83
9.155 USD
|
329
-0.6%
|
27,83
|
9.155 USD
|
|
|
2025-04-03 |
2025-04-01 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
5.546
-9.9%
27,83
154.331 USD
|
5.546
-9.9%
|
27,83
|
154.331 USD
|
|
|
2025-03-21 |
2025-03-20 |
GV
Geplanter Verkauf
|
Boyce Sarah
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
31.540
-9.3%
31,06
979.563 USD
|
31.540
-9.3%
|
31,06
|
979.563 USD
|
|
|
2025-03-21 |
2025-03-20 |
GV
Geplanter Verkauf
|
Flanagan W. Michael
Chief Scientific Officer
Führungsperson
|
11.780
-12.8%
31,06
365.868 USD
|
11.780
-12.8%
|
31,06
|
365.868 USD
|
|
|
2025-03-21 |
2025-03-20 |
GV
Geplanter Verkauf
|
Hughes Steven George
Chief Medical Officer
Führungsperson
|
9.578
-11.6%
31,06
297.491 USD
|
9.578
-11.6%
|
31,06
|
297.491 USD
|
|
|
2025-03-21 |
2025-03-20 |
GV
Geplanter Verkauf
|
MacLean Michael F
Chief Financial Officer
Führungsperson
|
7.935
-7.6%
31,06
246.425 USD
|
7.935
-7.6%
|
31,06
|
246.425 USD
|
|
|
2025-03-21 |
2025-03-20 |
GV
Geplanter Verkauf
|
McCarthy Teresa
Chief Human Resources Officer
Führungsperson
|
7.778
-7.4%
31,06
241.583 USD
|
7.778
-7.4%
|
31,06
|
241.583 USD
|
|
|
2025-03-12 |
2025-03-11 |
GV
Geplanter Verkauf
|
Flanagan W. Michael
Chief Scientific Officer
Führungsperson
|
20.000
-17.9%
30,13
602.614 USD
|
20.000
-17.9%
|
30,13
|
602.614 USD
|
|
|
2025-03-04 |
2025-03-03 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
5.875
-10.4%
29,41
172.807 USD
|
5.875
-10.4%
|
29,41
|
172.807 USD
|
|
|
2025-02-05 |
2025-02-03 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
5.875
-10.4%
32,16
188.918 USD
|
5.875
-10.4%
|
32,16
|
188.918 USD
|
|
|
2025-01-23 |
2025-01-22 |
GV
Geplanter Verkauf
|
Gallagher Kathleen P.
Chief Program Officer
Führungsperson
|
5.629
-10.0%
30,16
169.776 USD
|
5.629
-10.0%
|
30,16
|
169.776 USD
|
|
|
2025-01-23 |
2025-01-21 |
GV
Geplanter Verkauf
|
Flanagan W. Michael
Chief Scientific Officer
Führungsperson
|
1.812
-1.9%
28,59
51.809 USD
|
1.812
-1.9%
|
28,59
|
51.809 USD
|
|
|
2025-01-23 |
2025-01-21 |
GV
Geplanter Verkauf
|
Flanagan W. Michael
Chief Scientific Officer
Führungsperson
|
3.860
-4.0%
28,60
110.383 USD
|
3.860
-4.0%
|
28,60
|
110.383 USD
|
|
|
2025-01-23 |
2025-01-21 |
GV
Geplanter Verkauf
|
McCarthy Teresa
Chief Human Resources Officer
Führungsperson
|
1.221
-1.2%
28,60
34.917 USD
|
1.221
-1.2%
|
28,60
|
34.917 USD
|
|
|
2025-01-23 |
2025-01-21 |
GV
Geplanter Verkauf
|
McCarthy Teresa
Chief Human Resources Officer
Führungsperson
|
1.738
-1.6%
28,59
49.695 USD
|
1.738
-1.6%
|
28,59
|
49.695 USD
|
|
|
2025-01-23 |
2025-01-21 |
GV
Geplanter Verkauf
|
Boyce Sarah
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
5.659
-1.6%
28,59
161.817 USD
|
5.659
-1.6%
|
28,59
|
161.817 USD
|
|
